$NIVF

HRT FINANCIAL LP purchased $32K of NIVF

HRT FINANCIAL LP purchased 34,756 shares of NewGenIvf Group Ltd (NIVF) at an average of $0.92 ($0.88–$0.94) across 2 trades over 2026-06-02 to 2026-06-03.

Original reporting
SEC EDGAR · HRT FINANCIAL LP
Published Jun 4, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NIVF
Bullish
medium confidence
Mentioned
$NIVF
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NIVFBullishLow
01

Why it matters

The filing adds new information about ownership changes for NIVF, which was not previously public.

02

Market read

Insider buying may provide a modest bullish cue for traders, but the small transaction size limits broader impact.

03

What to watch

Potential upcoming clinical data or regulatory milestones could amplify the significance of insider activity.

Relevance 4/10Novelty 6/10Timing: post‑market June 4 2026

Background

Form 4 filings are primary disclosures of insider trades, required to be reported within two business days.

Company-level read

Ticker impact

$NIVFBullishMedium confidence
Context

SEC Form 4 shows HRT FINANCIAL LP bought 34,756 shares of NewGenIvf Group Ltd for $31,999.74, increasing its stake to 83,079 shares.

Expected impact

likely modest upward pressure as market absorbs insider buying

Evidence & confidence

The buyer is a 10% owner increasing its position; the transaction size is modest but signals confidence.

Market effects

Limited; reflects activity in the IVF biotech niche.

Minimal, primarily U.S. OTC/NASDAQ micro‑cap market.

Low; no broader market effect.

Counterpoint

The purchase is too small to move the stock; other investors may view it as routine insider rebalancing.

Key entities

  • NewGenIvf Group Ltd

    Biotech company focused on IVF technologies, ticker NIVF.

  • HRT FINANCIAL LP

    Investor holding a 10% ownership stake in NIVF.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MUMedAI 8/10

Dow Falls Over 200 Points; Micron Earnings Top Views

U.S. stocks fell Thursday, with the Dow Jones dropping 200 points. Micron (MU) reported Q4 revenue of $54.23B, beating estimates. Nexalin (NXL) and Stablecoin (SDEV) shares surged, while Corteva (CTVA) and NewGenIvf (NIVF) shares declined. Oil and gold prices rose, while European and Asian markets closed mixed.